European Pharma Leaders Push for National Reforms to Boost Investment
GSK PLC GSK
News
ViiV Healthcare Partners with Prevention Access Campaign (PAC) to Celebrate 10 Years of U=U and Look to The Future
Is the shingles vaccine the secret to living longer and delaying dementia? Here's what the science says.
Empowering Communities: ViiV Healthcare Awards $33 Million in Grants to Advance HIV Response in the U.S.
GSK Says New Lung-Cancer Drug Shows Benefits at Earlier Stage of Treatment
Hutchmed Enters Licensing Agreement With GSK for Cancer Drug
GSK Moves mRNA Flu Vaccine Candidate to Late-Stage Trial
GSK's Rectal Cancer Drug Jemperli Accepted for Priority Review by FDA
ViiV Healthcare Launches “Do It For Future You” Campaign Inspiring People to Prioritize Their Sexual Health and Future
GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline — Update
GSK Launches Cost-Saving Plan to Accelerate Drug Pipeline
GSK Gets U.S. Approval for Jideytro for Certain Lung Cancers
GSK Shares Slide After Drugmaker Drops Chronic Cough Treatment
GSK Stops Development of Drug Candidate for Chronic Cough
Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK — Update
GSK, Spero Therapeutics Gain U.S. Approval for Utebzi
Nuvalent Shares Leap Premarket on Takeover by GSK
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push — Update
Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology
GSK to Buy Nuvalent for $10.6 Billion in Oncology Push
United States